Trial Profile
A Study Evaluating Effect of Tocilizumab on Long-Term Patient and Renal-Allograft Survival in Patients With Antibody-Mediated Rejection and Transplant Glomerulopathy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Kidney disorders; Renal transplant rejection
- Focus Therapeutic Use
- 09 Nov 2016 New trial record